When is holmium laser indicated for cystoscopy, and what are the recommended technique settings, intra‑operative steps, and postoperative care?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Holmium Laser Cystoscopy: Indications, Technique, and Management

Holmium laser is the gold standard for endoscopic stone fragmentation during cystoscopy and ureteroscopy, with high-power settings (60-100W) significantly reducing operative time without increasing complications, and is also effective for ablation of recurrent non-muscle-invasive bladder tumors under local anesthesia. 1, 2

Primary Indications

Stone Disease (Primary Indication)

  • Bladder stones of any size or composition - particularly stones >1.5 cm where holmium laser demonstrates superior efficacy 2, 3, 4
  • Ureteral stones - holmium laser is preferred over other lithotripsy modalities for flexible ureteroscopy 5
  • Renal stones - especially when combined with flexible ureteroscopy for upper tract access 1, 6
  • Simultaneous treatment - bladder stones with benign prostatic obstruction can be managed concurrently with holmium laser enucleation of the prostate 7

Bladder Tumor Management (Secondary Indication)

  • Recurrent non-muscle-invasive bladder cancer (NMIBC) - particularly low-grade (G1/2, Ta) tumors 8
  • Local recurrence rates after holmium laser ablation: 4% for low-grade disease, 14% for high-grade (G3, T1) disease 8
  • Avoid treatment around ureteric orifices - significantly higher recurrence rates in this location 8

Recommended Technique Settings

For Stone Lithotripsy

High-Power Settings (Preferred):

  • Power: 60-100W 1, 2
  • "Pop Dusting" technique for large stones (>15 mm):
    • Stage 1 (contact mode): 0.2-0.5 J at 40-50 Hz for initial dusting 9
    • Stage 2 (non-contact mode): 0.5-0.7 J at 20-50 Hz for pop-dusting 9
  • High-frequency dusting approach for renal stones 6

Clinical Evidence: High-power (100W) settings reduce operative time from 70.8 minutes to 40.9 minutes compared to low-power (20W) settings for large bladder stones (>4 cm), with no increase in complications 2. Stone-free rates approach 100% for bladder stones and 84.5-94% for large urinary stones 2, 9.

Important Caveat: While high-power settings reduce lasering time, they have no proven clinical advantage in terms of final outcomes beyond operative efficiency 1.

For Tumor Ablation

  • Settings not explicitly defined in guidelines, but flexible cystoscopy with holmium laser under local anesthesia is feasible 8
  • Treatment successful throughout bladder except around ureteric orifices 8

Intraoperative Steps

For Bladder Stone Lithotripsy

  1. Patient positioning: Lithotomy position (standard); alternative positioning for patients with pelvic prosthesis 4

  2. Access and visualization:

    • Continuous irrigation resectoscope with laser bridge OR
    • Laser working element (e.g., Karl Storz) 2
    • Flexible cystoscope for local anesthesia cases 3, 4
  3. Stone fragmentation:

    • Complete stone removal is the goal 1
    • "Dust and go" should be limited to large renal stones only 1
    • Fragment extraction as needed
  4. Inspection: Direct visualization ensures complete stone clearance 10

For Ureteroscopic Stone Treatment

  1. Access considerations:

    • Routine prestenting not required but may improve outcomes for renal stones 1
    • Flexible ureteroscopy increasingly favored for upper tract access 1
  2. Lithotripsy execution:

    • Holmium laser is gold standard 1
    • Thulium fiber laser offers comparable efficacy 1
  3. Fragment management:

    • Basket extraction when feasible
    • Medical expulsive therapy (MET) after laser lithotripsy aids stone passage and reduces colic 1

Postoperative Care

Catheterization

  • Bladder stones: Foley catheter placed postoperatively 4
  • Mean catheterization duration: 29.3 hours 7
  • Mean hospital stay: 2.3 days for bladder stones 4, 34.8 hours for combined procedures 7

Stenting After Ureteroscopy

Routine post-URS stenting is unnecessary after uncomplicated procedures and may increase morbidity 1

Stenting IS indicated for:

  • Ureteral trauma
  • Residual fragments
  • Bleeding
  • Perforation
  • UTI
  • Pregnancy 1

Stent management: α-blockers improve stent tolerability 1

Adjuvant Medical Therapy

  • MET recommended after laser lithotripsy to enhance stone passage 1
  • Consider mechanical percussion and diuretics 1

Complications and Safety Profile

Stone Treatment Complications

  • Dysuria: 4.2%
  • Urinary frequency: 1.5%
  • Hematuria: 1.9%
  • Bladder perforation: 0% in reported series 8
  • UTI/sepsis: 3.9% (mostly Clavien II) 9
  • No transfusions required in modern series 7

Tumor Ablation Complications

  • Low complication rates with excellent patient tolerance
  • Mean pain score: 1/10 (range 0-7)
  • 100% patient satisfaction 8

Special Considerations

Anesthesia Options

  • General anesthesia: Standard approach
  • Local anesthesia: Feasible for selected patients with bladder stones or recurrent bladder tumors 3, 8, 4
  • Pain scores comparable between holmium laser cystolithotripsy and standard flexible cystoscopy under local anesthesia 4

Anticoagulation

  • Cystoscopy, flexible cystoscopy, and ureteroscopy classified as low-risk bleeding procedures 1
  • Can generally proceed with appropriate management of anticoagulation

Contraindications

  • Ureteroscopy: No specific contraindications aside from general anesthesia risks and untreated UTIs 1
  • Pregnancy: Contraindicated for ESWL but not specifically for cystoscopic procedures 1

Follow-up for Tumor Ablation

  • First cystoscopy at 3 months
  • Subsequent cystoscopies every 6 months for 2 years
  • Then every 6-12 months for 2 more years
  • Annual surveillance thereafter 11
  • Median time to local recurrence: 12 months 8

References

Guideline

2007 guideline for the management of ureteral calculi.

The Journal of urology, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.